• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】29029

【品名】4-chlorobenzaldehyde

【CA登记号】104-88-1

【 分 子 式 】C7H5ClO

【 分 子 量 】140.5688

【元素组成】C 59.81% H 3.59% Cl 25.22% O 11.38%

与该中间体有关的原料药合成路线共 11 条

合成路线1

该中间体在本合成路线中的序号:(II)

The condensation of 2-hydroxychloroacetophenone (I) with 4-chlorobenzaldehyde (II) by means of KOH in ethanol - water gives 4,5'-dichloro-2'-hydroxychalcone (III), which is cyclized by treatment with polyphosphoric acid (PPA) in reftuxing 2-methoxyethanol yielding 4',6-dichloroflavan (IV). Finally, this compound is reduced with Zn-Hg in acetic acid-hydrochloric acid.

1 Batchelor, J.F.; Bauer, D.J.; Hodson, H.F.; Selway, J.W.T.; Young, D.A.B. (Glaxo Wellcome plc); Flavans, process for their preparation and pharmaceutical compsns. containing them. EP 0004579 .
2 Serradell, M.N.; Castaner, J.; Hopkins, S.J.; Blancafort, P.; BW-683C. Drugs Fut 1982, 7, 8, 542.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 37094 1-(5-chloro-2-hydroxyphenyl)-1-ethanone 1450-74-4 C8H7ClO2 详情 详情
(II) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(III) 37095 (E)-1-(5-chloro-2-hydroxyphenyl)-3-(4-chlorophenyl)-2-propen-1-one C15H10Cl2O2 详情 详情
(IV) 37096 6-chloro-2-(4-chlorophenyl)-2,3-dihydro-4H-chromen-4-one C15H10Cl2O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

By reductocondensation of 4-chlorobenzaldehyde (I) with L-phenylalanine (II) by means of cyanoborohydride in methanol.

1 Ferres, H. (SmithKline Beecham plc); N-Substituted alpha-aminoacids, processes for making them and pharmaceutical compositions containing them. EP 0031653; ES 497907; JP 56092843 .
2 Castaner, J.; Serradell, M.N.; Thorpe, P.; BRL-26314. Drugs Fut 1985, 10, 1, 12.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(II) 13952 (S)-(-)-Phenylalanine; L-Phenylalanine 63-91-2 C9H11NO2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(X)

This compound can be prepared in several different ways: 1) By reaction of p-chlorobenzoyl chloride (I) with N-(2-aminoethyl)morpholine (II) in pyridine. 2) By reaction of p-chlorobenzoyl anhydride (III) with N-(2-aminoethyl)morpholine (II) in pyridine. 3) By reaction of methyl p-chlorobenzoate (IV) with N-(2-aminoethyl)morpholine (II) at 120 C. 4) By reaction of N-(p-chlorobenzoyl)succinimide (V) with N-(2-aminoethyl)morpholine (II) in dioxane. 5) By reaction of p-nitrophenyl p-chlorobenzoate (VI) with N-(2-aminoethyl)morpholine (II) in THF. 6) By reaction of p-chloro-N-(2-chloroethyl)benzamide (VII) with morpholine (VIII) at 100 C. 7) By reaction of p-chlorobenzoylaziridine (IX) with morpholine (VIII) in refluxing toluene. 8) By reaction of p-chlorobenzaldehyde (X) with N-(2-aminoethyl)morpholine (II) in refluxing benzene to give 4-[2-[(p-chlorobenzylidene)amino]ethyl]morpholine (XI), followed by an oxidation with H2O2 in methanol. 9) By reaction of p-chloro-N-(2-morpholinoethyl)thiobenzamide (XII) with lead tetraacetate in refluxing water. 11) By reaction of p-chlorobenzoic acid (XIV) with N-(2-aminoethyl)morpholine (II) by means of dicyclohexylcarbodiimide in pyridine, or by means of chloroformic acid ethyl ester and triethylamine in acetone. 10) By isomerization of (alpha-(p-chlorophenyl)-N-(2-morpholinoethyl)nitrone (XIII) in hot acetic acid - acetic anhydride, followed by a treatment with NaOH.

1 Bukard, W.; Wyss, P.C. (F. Hoffmann-La Roche AG); Benzamides. BE 0851422; CA 1076112; DE 2706179; FR 2340940; GB 1512194; JP 52100476; NL 7701144; US 4210754; ZA 7700488 .
2 Blancafort, P.; Serradell, M.N.; Castaner, J.; Grau, M.; Moclobemide. Drugs Fut 1983, 8, 2, 124.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10295 p-Chlorobenzoyl chloride; 4-Chlorobenzoyl chloride 122-01-0 C7H4Cl2O 详情 详情
(II) 12880 4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide 2038-03-1 C6H14N2O 详情 详情
(III) 30702 4-chloro-1-benzenecarboxylic anhydride C14H8Cl2O3 详情 详情
(IV) 30703 methyl 4-chlorobenzoate 1126-46-1 C8H7ClO2 详情 详情
(V) 30704 1-(4-chlorobenzoyl)-2,5-pyrrolidinedione C11H8ClNO3 详情 详情
(VI) 30705 4-nitrophenyl 4-chlorobenzoate C13H8ClNO4 详情 详情
(VII) 30706 4-chloro-N-(2-chloroethyl)benzamide C9H9Cl2NO 详情 详情
(VIII) 10388 Morpholine 110-91-8 C4H9NO 详情 详情
(IX) 30707 1-aziridinyl(4-chlorophenyl)methanone C9H8ClNO 详情 详情
(X) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(XI) 30708 N-[(E)-(4-chlorophenyl)methylidene]-2-(4-morpholinyl)-1-ethanamine; N-[(E)-(4-chlorophenyl)methylidene]-N-[2-(4-morpholinyl)ethyl]amine C13H17ClN2O 详情 详情
(XII) 30709 4-chloro-N-[2-(4-morpholinyl)ethyl]benzenecarbothioamide C13H17ClN2OS 详情 详情
(XIII) 30710 [(Z)-(4-chlorophenyl)methylidene][2-(4-morpholinyl)ethyl]ammoniumolate C13H17ClN2O2 详情 详情
(XIV) 18359 p-chlorobenzoic acid; 4-chlorobenzoic acid 74-11-3 C7H5ClO2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

The reaction of p-chlorobenzaldehyde (I) sodium cyanide and ethyl acetate gives ethyl 4-(p-chlorophenyl)-4-oxobutyrate (II), which is hydrolyzed with KOH to the corresponding free acid (III). The reduction of (III) with Zn and aqueous HCl affords 4-(p-chlorophenyl)butyric acid (IV), which is condensed with heptylamine (B) by means of oxalyl chloride (A) in refluxing benzene to yield N-heptyl-4-(p-chlorophenyl)butyramide (V), which is reduced with diborane in refluxing THF to afford N-heptyl-4-(p-chlorophenyl)butylamine (VI). The acetylation of (VI) with acetyl chloride (C) by means of Na2CO3 in acetone gives N-acetyl-N-heptyl-4-(p-chlorophenyl)butylamine (VII), which is reduced with diborane as before to yield N-ethyl-N-heptyl-4-(p-chlorophenyl)butylamine (VIII). The quaternization of (VIII) with refluxing ethyl bromide (D) gives N,N-diethyl-N-heptyl-4-(p-chlorophenyl)butylammonium bromide (IX), which by elution through a column with Dowex 1-X8, hydroxide form, resin is converted into N,N-diethyl-N-heptyl-4-(p-chlorophenyl)butyl ammonium hydroxide (X). Finally, this compound is salified with diluted aqueous phosphoric acid.

1 Molloy, B.B.; Steinberg, M.I.; EP 0002604 .
2 Hillier, K.; Castaner, J.; Clofilium Phosphate. Drugs Fut 1981, 6, 12, 764.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 23252 1-heptanamine; heptylamine 111-68-2 C7H17N 详情 详情
(A) 29841 Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride 79-37-8 C2Cl2O2 详情 详情
(D) 30344 1-bromoethane;ethyl bromide 74-96-4 C2H5Br 详情 详情
(I) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(II) 37460 ethyl 4-(4-chlorophenyl)-4-oxobutanoate C12H13ClO3 详情 详情
(III) 37461 4-(4-chlorophenyl)-4-oxobutyric acid 3984-34-7 C10H9ClO3 详情 详情
(IV) 37462 4-(4-chlorophenyl)butyric acid C10H11ClO2 详情 详情
(V) 37463 4-(4-chlorophenyl)-N-heptylbutanamide C17H26ClNO 详情 详情
(VI) 37464 N-[4-(4-chlorophenyl)butyl]-1-heptanamine; N-[4-(4-chlorophenyl)butyl]-N-heptylamine C17H28ClN 详情 详情
(VII) 37465 N-[4-(4-chlorophenyl)butyl]-N-heptylacetamide C19H30ClNO 详情 详情
(VIII) 37466 N-[4-(4-chlorophenyl)butyl]-N-ethyl-N-heptylamine; N-[4-(4-chlorophenyl)butyl]-N-ethyl-1-heptanamine C19H32ClN 详情 详情
(IX) 37467 N-[4-(4-chlorophenyl)butyl]-N,N-diethyl-1-heptanaminium bromide C21H37BrClN 详情 详情
(X) 37468 N-[4-(4-chlorophenyl)butyl]-N,N-diethyl-1-heptanaminium hydroxide C21H38ClNO 详情 详情
(C) 19273 acetyl chloride 75-36-5 C2H3ClO 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

A new synthesis of FTY-720 has been reported: Condensation of 4-chlorobenzaldehyde (I) with octylzinc iodide (II) by means of Ni(0) gives 4-octylbenzaldehyde (III), which is treated with vinylmagnesium bromide (IV) to yield the allyl alcohol (V). Epoxidation of (V) with MCPBA affords the epoxide (VI), which is opened by means of NaNO2 and MgSO4 in refluxing methanol to provide 3-nitro-1-(4-octylphenyl)propane-1,2-diol (VII). Reaction of diol (VII) with trimethylsilyl chloride and NaI in acetonitrile gives 3-nitro-1-(4-octylphenyl)-1-propene (VIII), which is hydrogenated with H2 over Pd/C in ethanol yielding the corresponding nitropropane derivative (IX). The bis-formylation of compound (IX) with aqueous HCHO in the presence of Amberlyst A-21 in dichloromethane affords 2-nitro-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol (X), which is finally reduced with H2 over Ra-Ni to provide FTY-720.

1 Kalita, B.; Barua, N.C.; Bez, G; Bezbarua, M.; Synthesis of 2-nitro alcohols by regioselective ring opening of epoxides with MgSO4/NeOH/NaNO2 system: A short synthesis of immunosuppressive agent FTY-720. Synlett 2001, 9, 1411.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(II) 53249 iodo(octyl)zinc n/a C8H17IZn 详情 详情
(III) 53250 4-Octylbenzaldehyde 49763-66-8 C15H22O 详情 详情
(IV) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(V) 53251 1-(4-octylphenyl)-2-propen-1-ol n/a C17H26O 详情 详情
(VI) 53252 (4-octylphenyl)(2-oxiranyl)methanol n/a C17H26O2 详情 详情
(VII) 53253 3-nitro-1-(4-octylphenyl)-1,2-propanediol n/a C17H27NO4 详情 详情
(VIII) 53254 1-[(E)-3-nitro-1-propenyl]-4-octylbenzene n/a C17H25NO2 详情 详情
(IX) 53255 1-(3-nitropropyl)-4-octylbenzene n/a C17H27NO2 详情 详情
(X) 53256 2-nitro-2-(4-octylphenethyl)-1,3-propanediol n/a C19H31NO4 详情 详情

合成路线6

该中间体在本合成路线中的序号:(III)

Esterification of L-tryptophan (I) by means of MeOH and SOCl2 gave the corresponding methyl ester (II). Subsequent Pictet-Spengler cyclization of (II) with 4-chlorobenzaldehyde (III) furnished the tetrahydropyridoindole (IV), which was dehydrogenated to the beta-carboline (V) using sulfur in refluxing xylene. The ester group of (V) was finally reduced to the target alcohol with LiAlH4 in THF.

1 Srivastava, S.K.; et al.; Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy. J Med Chem 1999, 42, 9, 1667.
2 Srivastava, S.K.; et al.; Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy. Bioorg Med Chem 1999, 7, 6, 1223.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30836 L-tryptophan 73-22-3 C11H12N2O2 详情 详情
(II) 30837 methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate C12H14N2O2 详情 详情
(III) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(IV) 30834 methyl 1-(4-chlorophenyl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate C19H17ClN2O2 详情 详情
(V) 30835 methyl 1-(4-chlorophenyl)-9H-beta-carboline-3-carboxylate C19H13ClN2O2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(IX)

The reaction of 3,5-dihydroxybenzoic acid (I) with N,O-dimethylhydroxylamine (II) by means of EDC and NMM in dichloromethane gives the N,O-dimethylbenzamide (III), which is alkylated with butyl bromide (IV) and K2CO3 in hot DMF to yield the dibutoxybenzamide (V). The condensation of (V) with 4-methylpyridine (VI) by means of LDA in THF affords 1-(2,4-dibutoxyphenyl)-2-(4-pyridyl)ethanone (VII), which is oxidized with SeO2 in hot acetic acid to provide the dione (VIII). Finally, this compound is cyclized with 4-chlorobenzaldehyde (IX) and ammonium acetate in refluxing acetic acid to furnish the target imidazole.

1 Chang, L.L.; et al.; Substituted imidazoles as gluagon receptor antagonists. Bioorg Med Chem Lett 2001, 11, 18, 2549.
2 de Laszlo, S.; O'Keefe, S.; Li, B.; MacCoss, M.; Rolando, A.; mantlo, N.; Koch, G.; Cascieri, M.A.; Hagmann, W.K.; Chang, L.L.; Pang, M.; Sidler, K.L.; Selective, non-peptide antagonists for the glucagon receptor: Substituted imidazoles. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 237.
3 Chang, L.L. (Merck & Co., Inc.); Triaryl substd. imidazoles as glucagon antagonists. EP 0959886; JP 2000514088; US 5880139; WO 9822109 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48820 2,4-Dihydroxybenzenecarboxylic acid; 2,4-Dihydroxybenzoic acid; beta-Resorcylic acid; Resorcinol-4-carboxylic acid 89-86-1 C7H6O4 详情 详情
(II) 13361 (Methoxyamino)methane; N,O-Dimethylhydroxylamine 1117-97-1 C2H7NO 详情 详情
(III) 48821 2,4-dihydroxy-N-methoxy-N-methylbenzamide C9H11NO4 详情 详情
(IV) 28721 1-bromobutane 109-65-9 C4H9Br 详情 详情
(V) 48822 2,4-dibutoxy-N-methoxy-N-methylbenzamide C17H27NO4 详情 详情
(VI) 31150 4-methylpyridine 108-89-4 C6H7N 详情 详情
(VII) 48823 1-(2,4-dibutoxyphenyl)-2-(4-pyridinyl)-1-ethanone C21H27NO3 详情 详情
(VIII) 48824 1-(2,4-dibutoxyphenyl)-2-(4-pyridinyl)-1,2-ethanedione C21H25NO4 详情 详情
(IX) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情

合成路线8

该中间体在本合成路线中的序号:(I)

The beta-amino acid (II) was prepared by Knoevenagel condensation of 4-chlorobenzaldehyde (I) with malonic acid in the presence of ammonium acetate. After protection of the amino group of (II) with Fmoc-Cl, the protected amino acid (III) was attached to the trityl chloride polystyrol resin, yielding the amino acid-bound resin (IV). The Fmoc group of (IV) was then removed using piperidine in DMF to afford (V). N-Fmoc-hydrazine (VI) was carbonylated with phosgene to obtain the oxadiazolone (VII). This was condensed with the amino resin (V) producing adduct (VIII). Deprotection of the Fmoc group of (VIII), followed by coupling with N-Fmoc-3-aminobenzoic acid (IX), furnished (X). After a new deprotection of (X) with piperidine in DMF, the guanidino group was introduced by condensation with N,N'-bis-Boc-1-guanylpyrazole to give (XI). Finally, deprotection and cleavage of the resin adduct (XI) was carried out with trifluoroacetic acid in the presence of triisopropylsilane.

1 Sulyok, G.A.G.; et al.; Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alphavbeta3 integrin antagonists. J Med Chem 2001, 44, 12, 1938.
2 Sulyok, G.; Kessler, H.; Holzemann, G.; Goodman, S.; Gibson, C. (Merck Patent GmbH); Diacylhydrazine derivs.. DE 19932796; WO 0105753 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II),(V) 49780 3-Amino-3-(4-chlorophenyl)propionic acid C9H10ClNO2 详情 详情
(III),(IV) 49781 3-(4-chlorophenyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-beta-alanine C24H20ClNO4 详情 详情
(I) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(VI) 49782 9-Fluorenylmethyl carbazate; Fmoc-hydrazide 35661-51-9 C15H14N2O2 详情 详情
(VII) 49783 5-(9H-fluoren-9-ylmethoxy)-1,3,4-oxadiazol-2(3H)-one C16H12N2O3 详情 详情
(VIII) 49784 3-(4-chlorophenyl)-N-([2-[(9H-fluoren-9-ylmethoxy)carbonyl]hydrazino]carbonyl)-beta-alanine C25H22ClN3O5 详情 详情
(IX) 49785 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzoic acid C22H17NO4 详情 详情
(X) 49786 3-(4-chlorophenyl)-N-[[2-(3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzoyl)hydrazino]carbonyl]-beta-alanine C32H27ClN4O6 详情 详情
(XI) 49787 N-([2-[3-([[(tert-butoxycarbonyl)amino][(tert-butoxycarbonyl)imino]methyl]amino)benzoyl]hydrazino]carbonyl)-3-(4-chlorophenyl)-beta-alanine C28H35ClN6O8 详情 详情

合成路线9

该中间体在本合成路线中的序号:(II)

Condensation between 2-(3,4-dimethoxyphenyl)ethylamine (I) and 4-chlorobenzaldehyde (II) in refluxing toluene affords imine (III). Then, Pictet-Spengler cyclization of imine (III) in the presence of trifluoroacetic acid leads to the tetrahydroisoquinoline (IV). This is further acylated in boiling acetic anhydride to produce the target acetamide.

1 Gitto, A.; Barreca, M.L.; De Luca, L.; De Sarro, G.; Ferreri, G.; Quartarone, S.; Russo, E.; Constanti, A.; Chimirri, A.; Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist. J Med Chem 2003, 46, 1, 197.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10098 2-(3,4-Dimethoxyphenyl)-1-ethanamine; 3,4-Dimethoxyphenethylamine; 2-(3,4-Dimethoxyphenyl)ethylamine 120-20-7 C10H15NO2 详情 详情
(II) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(III) 65051 N-[(E)-(4-chlorophenyl)methylidene]-2-(3,4-dimethoxyphenyl)-1-ethanamine; N-[(E)-(4-chlorophenyl)methylidene]-N-(3,4-dimethoxyphenethyl)amine C17H18ClNO2 详情 详情
(IV) 65052 1-(4-chlorophenyl)-6-methoxy-1,2,3,4-tetrahydro-7-isoquinolinyl methyl ether; 1-(4-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline C17H18ClNO2 详情 详情

合成路线10

该中间体在本合成路线中的序号:(VII)

 

1 Murugesan B, Rafe M, Sathyananarayana S(Ranbaxy Laboratories Limited, India). 2007. A process for the preparation of dichlorofluorene as a key intermediate to lumefantrine. Indian Pat Appl, IN 2007DE00012.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 67236 Fluorene;Diphenylenemethane;2,2'-Methylenebiphenyl;2,3-Benzindene;o-Biphenylenemethane;alpha-Diphenylenemethane-9H-fluorene 86-73-7 C13H10 详情 详情
(III) 67237 2,7-dichloro-9H-fluorene 7012-16-0 C13H8Cl2 详情 详情
(IV) 67240 2-(2,7-dichloro-9H-fluoren-4-yl)oxirane 53221-14-0 C15H10Cl2O 详情 详情
(V) 33492 N,N-dibutylamine; N-butyl-1-butanamine 111-92-2 C8H19N 详情 详情
(VI) 67241 2-(dibutylamino)-1-(2,7-dichloro-9H-fluoren-4-yl)ethanol 69759-61-1 C23H29Cl2NO 详情 详情
(VII) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(IX) 67246 sulfuryl dichloride 7791-25-5 Cl2O2S 详情 详情

合成路线11

该中间体在本合成路线中的序号:(XIII)

Intermediate (XIb) is prepared by condensation of 4-chlorobenzaldehyde (XIII) with NH4OH and (S)-(+)-epichlorohydrin (XIV) in MTBE or MeOH to yield imine (XV). Then imine (XV) is condensed with carbamate (VI) using t-BuOLi to give the 2-oxazolidinone derivative (XVI), which is finally hydrolyzed with HCl in EtOAc/H2O .

1 Brickner, S.J., Nuermberger, E., Stover, C.K. (Pfizer, Inc.). Combination therapy for tuberculosis. CN 102143748, EP 2340022, JP 20122502017, KR 2011063518, US 2011190199, WO 2010026526.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIb) 68067 (R)-5-(aminomethyl)-3-(3-fluoro-4-thiomorpholinophenyl)oxazolidin-2-one hydrochloride   C14H18FN3O2S.HCl 详情 详情
(VI) 68062 benzyl (3-fluoro-4-thiomorpholinophenyl)carbamate   C18H19FN2O2S 详情 详情
(XIII) 29029 4-chlorobenzaldehyde 104-88-1 C7H5ClO 详情 详情
(XIV) 13917 (S)-Epichlorohydrin; (2S)-2-(Chloromethyl)oxirane;(S)-(+)-epichlorohydrin 67843-74-7 C3H5ClO 详情 详情
(XV) 68068 (R,E)-1-chloro-3-((4-chlorobenzylidene)amino)propan-2-ol   C10H11Cl2NO 详情 详情
(XVI) 68069 (R,E)-5-(((4-chlorobenzylidene)amino)methyl)-3-(3-fluoro-4-thiomorpholinophenyl)oxazolidin-2-one   C21H21ClFN3O2S 详情 详情
Extended Information